VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,386 | +11.3% | 61,500 | +12.6% | 0.02% | +6.2% |
| Q2 2023 | $19,214 | +97.4% | 54,600 | +76.7% | 0.02% | +77.8% |
| Q1 2023 | $9,735 | -25.7% | 30,900 | -31.9% | 0.01% | -35.7% |
| Q4 2022 | $13,110 | -99.9% | 45,400 | -4.4% | 0.01% | -12.5% |
| Q3 2022 | $13,753,000 | -3.9% | 47,500 | -6.5% | 0.02% | +6.7% |
| Q2 2022 | $14,314,000 | -21.1% | 50,800 | -26.9% | 0.02% | -11.8% |
| Q1 2022 | $18,137,000 | +25.0% | 69,500 | +5.1% | 0.02% | +13.3% |
| Q4 2021 | $14,515,000 | -15.5% | 66,100 | -22.2% | 0.02% | -6.2% |
| Q3 2021 | $17,187,000 | +0.4% | 85,000 | +0.1% | 0.02% | -5.9% |
| Q2 2021 | $17,118,000 | +14.6% | 84,900 | +12115.8% | 0.02% | -37.0% |
| Q1 2021 | $14,934,000 | – | 695 | +46.6% | 0.03% | – |
| Q4 2020 | $0 | – | 474 | +91.1% | 0.00% | – |
| Q3 2020 | $0 | – | 248 | -39.4% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 409 | -16.7% | 0.00% | -100.0% |
| Q1 2020 | $11,683,000 | -10.8% | 491 | -17.9% | 0.02% | -27.6% |
| Q4 2019 | $13,093,000 | -3.4% | 598 | -25.2% | 0.03% | -25.6% |
| Q3 2019 | $13,553,000 | +38.4% | 800 | +49.8% | 0.04% | +44.4% |
| Q2 2019 | $9,792,000 | -19.7% | 534 | -19.5% | 0.03% | -20.6% |
| Q1 2019 | $12,195,000 | -9.9% | 663 | -18.8% | 0.03% | -15.0% |
| Q4 2018 | $13,538,000 | +162.1% | 817 | +204.9% | 0.04% | +135.3% |
| Q3 2018 | $5,165,000 | -46.9% | 268 | -53.1% | 0.02% | -55.3% |
| Q2 2018 | $9,721,000 | +1794.9% | 572 | -2.6% | 0.04% | +65.2% |
| Q1 2018 | $513,000 | -51.7% | 587 | +83.4% | 0.02% | -50.0% |
| Q4 2017 | $1,063,000 | -38.5% | 320 | -58.1% | 0.05% | -35.2% |
| Q3 2017 | $1,728,000 | +69.7% | 763 | -8.9% | 0.07% | +61.4% |
| Q2 2017 | $1,018,000 | -41.3% | 838 | -12.0% | 0.04% | -41.3% |
| Q1 2017 | $1,733,000 | +604.5% | 952 | +27.3% | 0.08% | +400.0% |
| Q4 2016 | $246,000 | +602.9% | 748 | +202.8% | 0.02% | +650.0% |
| Q3 2016 | $35,000 | +52.2% | 247 | +100.8% | 0.00% | 0.0% |
| Q2 2016 | $23,000 | +21.1% | 123 | +35.2% | 0.00% | 0.0% |
| Q1 2016 | $19,000 | -95.7% | 91 | -52.4% | 0.00% | -94.1% |
| Q4 2015 | $439,000 | +66.9% | 191 | -30.0% | 0.03% | +78.9% |
| Q3 2015 | $263,000 | -12.3% | 273 | +56.9% | 0.02% | -24.0% |
| Q2 2015 | $300,000 | +49.3% | 174 | +23.4% | 0.02% | +8.7% |
| Q1 2015 | $201,000 | -84.6% | 141 | -55.4% | 0.02% | -85.4% |
| Q4 2014 | $1,301,000 | – | 316 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 99,400 | $34,565,356 | 0.12% |
| SIMPLEX TRADING, LLC | 61,500 | $21,386 | 0.02% |
| IMC-Chicago, LLC | 47,900 | $16,656,746 | 0.02% |
| JANE STREET GROUP, LLC | 119,000 | $41,381,060 | 0.01% |
| Allianz Asset Management GmbH | 19,700 | $6,850,478 | 0.01% |
| SG Americas Securities, LLC | 59,600 | $593 | 0.01% |
| Maven Securities LTD | 900 | $312,966 | 0.00% |
| JPMORGAN CHASE & CO | 40,500 | $14,083,470 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 1 | $5,420 | 0.00% |